Zynrelef

Active Ingredient(s): Bupivacaine + Meloxicam
FDA Approved: * May 12, 2021
Pharm Company: * Heron Therapeutics, Inc.
Category: Anesthetic

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Zynrelef Overview

Bupivacaine/meloxicam, sold under the brand name Zynrelef, is a fixed-dose combination medication used to treat pain in small to medium-sized wounds after surgery.[1][2] It contains bupivacaine and meloxicam.[1][2] The most common side effects of bupivacaine/meloxicam are dizziness, constipation, vomiting, and headache.[1][2] It was approved for medical use in the European Union in September 2020,&...

Read more Zynrelef Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Bupivacaine/meloxicam

Recent Zynrelef Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Bupivacaine + Meloxicam
  • Solution: 200mg/6mg, 300mg/9mg, 400mg/12mg, 60mg/1.8mg
  • Solution, Extended Release: 200mg/7ml (29.25mg/ml) + 6mg/7ml (0.88mg/ml), 300mg/10.5ml (29.25mg/ml) + 9mg/10.5ml (0.88mg/ml), 400mg/14ml (29.25mg/ml) + 12mg/14ml (0.88mg/ml), 60mg/2.3ml (29.25mg/ml) + 1.8mg/2.3ml (0.88mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Zynrelef: (4 results)

Sorted by National Drug Code
  • 47426-301 Zynrelef Infiltration Solution by Heron Therapeutics, Inc.
  • 47426-302 Zynrelef Infiltration Solution by Heron Therapeutics, Inc.
  • 47426-303 Zynrelef Infiltration Solution by Heron Therapeutics, Inc.
  • 47426-304 Zynrelef Infiltration Solution by Heron Therapeutics, Inc.

Drugs with one or more similar ingredients: (22 results)